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“A Prospective Randomized Controlled  Study Comparing  The 
Analgesic Efficacy Of Dexamethasone When Added To 
Bupivacaine  In Supraclavicular Brachial Plexus Block For 
Upper Limb Surgeries   ” 
                        Dr.P.Nishitha,  Prof.Dr.Kamalini Sridharan ,  Dr.K.Radhika  
Background: 
Different adjuvants have been used to improve the quality and increase the duration of 
local anesthetics during various nerve blocks. The current study compared the analgesic 
efficacy of dexamethasone  as an adjuvant  to bupivacaine  in supraclavicular brachial  plexus 
block . 
Aims and objectives: 
To compare the analgesic efficacy of dexamethasone added to bupivacaine and 
bupivacaine alone in supraclavicular  brachial plexus block for upper limb surgeries on 
various parameters like onset of sensory and motor blockade and  duration of analgesia. 
Materials and methods: 
80 patients undergoing upper limb surgeries under supraclavicular block were 
grouped into Group D (study group)  who received 0.5% bupivacaine (25 ml) and 
epinephrine 1ml of 1 in 1000 ml + dexamethasone  8 mg (2ml) and Group B(control group)  
who received  0.5% bupivacaine (25 ml) and epinephrine 1ml of 1 in 1000 + distilled water 
2ml.Total volume in both groups were 28ml. 
Results: 
Mean onset of  sensory block 4.2±0.99, 13.6±6  minutes  in group D and group B. 
Mean onset of motor block  7.5±3.2 , 11.5±3.43 minutes in group D and  group B. Duration 
of analgesia  18.97±2.67, 9.10±1.79 hours in group D and group B. The early onset of motor 
and sensory block and duration of analgesia were statistically significant in group D. The 
time to reach vas score  of 2 and 4 were significantly longer in group D when compared to 
group B. 
Conclusion:  
Dexamethasone in the dose of 8mg given as an adjuvant in supraclavicular block ,  
results in early onset of motor and sensory block  .The  duration of analgesia is  also 
prolonged significantly .  This prolonged postoperative pain relief  helps  in   early 
mobilisation   and   thereby  improving   physical  and   psychological   wellbeing    of  the   
patient .  This  dose  is optimal  in  that  it  does  not  cause  any  any  side  effects,   at  the  
same  time it provides excellent  perioperative and   postoperative analgesia. 
Keywords: 
Supraclavicular block,  bupivacaine ,  Dexamethasone. 
INTRODUCTION
“Pain has been defined as an unpleasant sensory or emotional
experience associated with actual or potential tissue damage1”.
Pain is gaining importance as the fifth vital sign along with pulse
rate, blood pressure, respiratory rate and temperature. Anaesthesia for
surgery should be a pleasant experience to the patient hence the
anaesthesia   plan should also account for postoperative pain relief.
Peripheral nerve block can be used as a sole anaesthetic technique.
When used alone side effects of sedation, nausea and vomiting
dueopioids    are avoided. Patients are pain free and can be discharged as
day care. Sedation when combined with nerve block improves patient
comfort  and  tolerance  of  block.   Brachial  plexus  block    is  a  type  of
regional anaesthetic technique for upper limb surgeries. The plexus can
be  blocked  at  the  level  of  the  roots,  trunks,  cords  or  the  divisions.  The
block can be performed by using the ultrasound  guidance or with nerve
stimulator  or using the land marks as a guidance. Local anaesthetic
agents  can be  given either solely  or an adjuvant drug can be added,
which prolongs the duration of the plexus blockade.
The  adjuvant  drug  may  be  in  the  form  of   vaso  constrictor  ,  for
example epinephrine2  or  sedatives    like  tramadol3, fentanyl4 and
buprenorphine5. Alpha receptor agonist like clonidine2,6 and
dexmedetomidine7 have also been used safely. Steroids like
dexamethasone have been found to have an effect on prolonging the
block duration.
AIM
? TO   COMPARE    THE   ANALGESIC   EFFICACY   OF
DEXAMETHASONE  ADDED   TO   BUPIVACAINE
VERSUS  BUPIVACAINE ALONE IN SUPRACLAVICULAR
BRACHIAL PLEXUS BLOCK FOR  UPPER LIMB
SURGERIES.
OBJECTIVE
? ONSET OF SENSORY AND MOTOR BLOCKADE.
? DURATION OF ANALGESIA.
REVIEW OF LITERATURE
Shrestha BR et al in another study compared the analgesic efficacy
of local anesthetic with and without dexamethasone (8 mg) in
supraclavicular brachial plexus block in  forty patients  . Addition of
dexamethasone for brachial plexus  block significantly prolonged the
duration of analgesia without any unwanted effects8.
In   double   blinded   study  by  Movafegh  A  et  al,  the   effect   of
dexamethasone   added    to   lidocaine   on   the  onset  and  duration  of
axillary brachial plexus block was evaluated  in  sixty  patients .  34 ml of
1.5% lidocaine was used in axillary block with or without 8 mg of
dexamethasone.  It    was     concluded   that   the   addition   of
dexamethasone(8mg)   to   lidocaine     1.5%   solution  in  axillary   block
significantly  prolongs  the  duration   of   both   sensory   and   motor
blockade9.
Shrestha BR in a   double blinded study   evaluated   post operative
analgesia     after  the addition of  Tramadol (2mg/kg) or dexamethasone
(8 mg) to bupivacaine in supraclavicular blocks . Sixty patients was
studied. Duration of analgesia was two and half times prolonged in
dexamethasone group compared to tramadol group10.
Yadav  RK  et  al   did   a  study  comparing   dexamethasone   and
neostigmine   as adjuvants  added to lignocaine  with adrenaline  for
brachial  plexsus  block. They  concluded   that  the  onset   of   blockade
and   the   duration   of   analgesia  was  better  in  third
(dexamethasone)group11.
In   a   study   conducted by   Parrington et  al , ultrasound guidance
was used to administer supraclavicular  brachial  plexus  block.  30 ml of
mepivacaine  1.5%  was used with or without  8 mg dexamethasone  as an
adjuvant. Their study concluded that  the addition of dexamethasone 8 mg
to  mepivacaine   significantly   prolonged  the  duration  of  analgesia  but
does not reduce the onset  time  of sensory and motor blockade12.
Vieira  PA et  al  did   another   randomised  double  blinded  study  to
determine  the  addition  of dexamethasone to interscalene brachial plexus
block in  eighty eight  individuals undergoing shoulder arthroscopy.
20 ml of the  bupivacaine  0.5%  with 1:200,000 epinephrine  and
clonidine  75  micrograms  was  used  .  They  concluded  that  addition  of
dexamethasone to a bupivacaine epinephrine-clonidine in  interscalene
block  prolongs  sensory  block and  reduces  opioid  use13.
Islam SM et al did a study comparing lignocaine bupivacaine
mixture  of  local  anesthetic  35  ml  with  or  without  addition  of
dexamethasone 8 mg.  They concluded that addition of dexamethasone as
an adjuvant to local anaesthetics in brachial plexus block results in
significantly early onset and markedly prolonged duration of analgesia
without any unwanted effects14.
  K.  C.  Cummings  III  et  al   in   another   study   compared
bupivacaine or ropivacaine alone  or  dexamethasone  8 mg  added  either
to bupivacaine  or ropivacaine  in  interscalene  nerve  blocks .   Volume
of the local anesthetic used was 30 ml. They concluded that when
dexamethasone  (8mg)    is  added  to     ropivavaine  or  bupivacaine  ,  the
analgesia is prolonged  to  22 hours  in both the  group of patients15.
Tandoc  et  al  in  another   study     compared  the  effects      of
adding   two   different   doses   of   dexamethasone  on  the  duration  and
quality   of   interscalene  block  in  ninety patients.   One group received
4mg  of  dexamethasone   and  another  group  received  8  mg  of
dexamethasone.   They   concluded    the  addition  of  dexamethasone  to
bupivacaine     significantly    prolonged    the  duration    of    the  motor
block and improved the quality of analgesia following interscalene block.
There was  no difference in the duration of  analgesia  and  motor  block
between  low-dose and  high-dose dexamethasone16.
Pathak et al   in another study   compared   supraclavicular brachial
plexus   block   with and without  dexamethasone ( 8mg).  38 ml of the
local anesthetic was given.  They concluded that addition of
dexamethasone to local anaesthetic drugs in brachial plexus block
significantly  prolongs  the  duration  of   analgesia  and  motor  block   in
patients  and is remarkably safe and cost effective method of providing
post operative analgesia17.
Yaghoobi et  al   in  another    study   compared    the     analgesic
efficacy  of   the  dexamethasone  and fentanyl  added  to  lidocaine  using
axillary  block in seventy-eight patients. They concluded  that addition of
dexamethasone  to  lidocaine  significantly  prolonged  the  duration  of
analgesia   compared   with   fentanyl/lidocaine  mixture   or   plain
lidocaine18.
In a retrospective database analysis, Rasmussen et al reviewed
1,040  patient records collected in an orthopedic outpatient surgery center
that had received an upper or lower extremity peripheral nerve block with
ropivacaine 0.5% with or without dexamethasone and/or epinephrine. The
primary outcome evauluated was the duration of analgesia in upper or
lower extremity blocks containing dexamethasone as an adjuvant. They
concluded that the addition of dexamethasone to 0.5% ropivacaine
prolongs  the  duration of peripheral nerve blocks  of  both  the upper  and
lower  extremity19.
Recently, Choi et al  reviewed the contemporary literature and did
a  meta  -  analysis   of   all   randomised   control   trials   on   the  effects  of
dexamethasone as a  local  anaesthetic adjuvant for brachial plexus block:
The objectives of meta-analysis were to assess the contemporary
literature and quantify  the effects  of  dexamethasone on Brachial plexus
block  .  Meta  -  analysis    was  performed    as  nine  trials  in  801  patients
with 393 patients receiving dexamethasone (4–10 mg).
Dexamethasone prolonged the analgesic duration for long-acting
local anesthetic. The most recent trial demonstrated equivalent
prolongation with perineural or systemic administration of
dexamethasone   compared with placebo.  They  concluded  that
perineural  administration of dexamethasone with local anaesthetic
prolongs  brachial   plexus   block    effects   with   no   observed   adverse
events20.
Santhosh kumar et al  did  a comparative evaluation of ropivacaine
and ropivacaine  with dexamethasone  in supraclavicular brachial block
for post operative analgesia in eighty patients. 40 ml of  local anesthetic
solution was given to both group of patients. They concluded that
dexamethasone 8 mg as an adjuvant  had significantly prolonged  both
motor and sensory blockade than ropivacaine alone21 .
BRACHIAL PLEXUS ANATOMY
 FORMATION FROM VENTRAL RAMI
The  brachial   plexus  is     formed   from  the  ventral  rami  of  the
lower four cervical nerves  and  first  thoracic nerves to give rise to the
root value of C5, C6, C7, C8 and  T1.  C4 and T2 make minor
contributions.    These  are  collectively  known    as  the  ROOTS  of  the
ventral rami.   After exiting through the corresponding intervertebral
foramen, the  roots  of  the  plexus  are  found  in  the  cervical
paravertebral  space,  between  the  anterior and  middle  scalene
muscles.    The  ventral  rami contains  both the sensory and motor fibres
supplying the  anterior  trunks   and limbs and over lying skin22.

Interscalene  block  is  given  at the level of roots .  This block is
effective  for   shoulder and upper arm surgeries.  Ulnar nerve is spared in
this block.
TRUNKS   : Ventral rami unite to form three trunks.  The trunks are
formed between the scalene muscle and the upper border of the clavicle
in the posterior triangle of the neck22.
UPPER TRUNK C5,C6
MIDDLE TRUNK C7
LOWER TRUNK C8-T1
Upper, middle, and lower trunks course over the lateral border of
the first rib and under the clavicle. Supraclavicular block is given at the
level  of  trunks.  No nerve is spared in this block.  This block is given for
arm , forearm, hand surgeries.
DIVISIONS
       Under  this   location,  each   trunk   will   separate    into   anterior  and
posterior divisions  which   supplies  extensor and flexor  compartments22.
CORD
As the brachial plexus emerges under the clavicle, the anterior and
posterior divisions come together to form three cords. The lateral cord is
lateral to the axillary artery; the posterior cord is located posterior to the
axillary artery; and the medial cord is located medial to the axillary
artery22.
LATERAL CORD– formed  by the anterior divisions of the upper
and  middle trunks.
POSTERIOR  CORD -  formed  by  the   posterior  divisions  of  all
three trunks.
MEDIAL CORD -   formed by the  anterior divisions of the lower
trunk.
At the lateral border of the pectoralis minor muscle, each cord
divides into branches, terminating in individual nerves.
Axillary  block  is  given  at  the  level   of  terminal  branches  .   It   is
given  for  forearm and  hand surgeries.  Musculocutaneous nerve is
spared  in  this  block.
A  sheath  surrounds  the  brachial  plexus,  from  the  transverse
processes all the way down into the axilla.
The brachial plexus is enveloped by a fascial sheath, formed by
prevertebral and scalene fascia, extending from the intervertebral
foramina to  the upper arm. The formation of a sheath allows for the
administration of brachial plexus anesthesia.
 Injection into the sheath, at any anatomical point, will allow for
the spread of local anesthetics and subsequent blockade. Each approach
to the brachial plexus impacts specific anatomical areas of the upper
extremity. Choice of a specific technique should be made based on the
surgical procedure.
Distribution of the branches of the brachial plexus
Axillary nerve (C5-C6): gives an articular branch to the shoulder joint,
motor innervation to the  deltoid  and teres minor muscles and sensory
innervation to part of deltoid and scapular regions.
Radial nerve (C5-C6-C7-C8):  supplies  the  skin  of  the  posterior  and
lateral arm down to the elbow, the posterior forearm down to the wrist,
lateral  part  of  the dorsum of the hand and the dorsal  surface of  the first
three and one-half fingers proximal to the nail beds. It also provides
motor innervation to the triceps, anconeus, part of the brachialis,
brachioradialis, extensor carpi radialis and all the extensor muscles of the
posterior compartment of the forearm. Its injury  produces a characteristic
“wrist drop”.
Median nerve (C5-C6-C7-C8-T1): gives off no cutaneous or motor
branches in the axilla or the arm. In the forearm it provides motor
innervation to the anterior compartment except the flexor carpi ulnaris
and the medial half of the flexor digitorum profundus (ulnar nerve). In the
hand it provides motor innervation to the thenar eminence and the first
two lumbricals.  It  provides  the  sensory  innervation  of  the  lateral  half  of
the palm of the hand and dorsum of first three and one half  fingers
including the nail beds.
Ulnar nerve (C8-T1): like the median nerve, the ulnar nerve does not
give off  branches in the axilla  or  the arm. Its  motor component supplies
the flexor carpi ulnaris and the medial half of the flexor digitorum
profundus. In the hand it provides the motor supply to all the small
muscles of the hand except the thenar eminence and first two lumbricals
(median). Its sensory branches supply the medial third of the dorsum and
palmar sides of the hand and dorsum of the 5th finger and dorsum of the
medial side of 4th finger.
Medial brachial cutaneous nerve (T1):  it  is  solely  a  sensory  nerve.  It
supplies  the  skin  of  the  medial  side  of  the  arm.  It  is  joined  here  by  the
intercostobrachial nerve, branch of the second intercostal.
Medial antebrachial cutaneous nerve (C8-T1):  It  is  also  a  sensory
nerve. It supplies the medial side of the anterior forearm.
Musculocutaneous nerve (C5-C6-C7): gives motor innervation to the
choracobrachialis, biceps  and brachialis muscles. At the elbow it
becomes purely sensory innervating the lateral anterior aspect of the
forearm to the wrist.
                        Cutaneous Nerve Supply of the upper limb
This figure shows the cutaneous innervation and root values  of
the terminal branches of the brachial plexus.
Major Motor Function of the Individual Nerves .
               Nerve         Motor Function
Axillary Abduction of the shoulder
Musculocutaneous Flexion of the elbow
Radial Extension of elbow, wrist, and finger
Median Flexion of the wrist and finger
Ulnar Flexion of the wrist and  finger.
Sonoanatomy  showing  the  brachial  plexsus  between the scalene
muscle
This figure shows the sonographic  relationship of the brachial
plexus  in  relation  to  the  subclavian   artery,  the  first  rib  and  the
pleura .
This figure shows the sonographic image of the spread of the local
anesthetic within the brachial plexus
BRACHIAL PLEXUS BLOCK
First   performed by Halsted in 1841.  It blocks the trunks roots,
divisions and cords of the brachial plexus .Its anatomic compactness is
responsible for complete and reliable anaesthesia. Advantage include
rapid onset and ability to perform with the patient's  arm in any position.
It involves  injecting  the local anasthetic drug in the fascial planes
surrounding the nerve plexus  and  there by blocking the autonomic
,motor and sensory  fibers  supplying  the upper extremity.22
ANATOMICAL TECHNIQUES OF BLOCKADE OF UPPER
EXTREMITY
? Inter-scalene brachial plexus block
? Supraclavicular brachial plexus block
? Vertical  infraclavicular plexus block
? Suprascapular nerve block
? Axillary plexus block
? Blocks in the upper arm region (mid-humeral approach for the
radial nerve)
? Blocks in the region of the elbow (radial, musculocutaneous
,median and ulnar nerves).
SUPRACLAVICULAR BLOCK :(  Blocks the dermatome C5 to T1)
? The supraclavicular  block is   often  called  as    "spinal  anesthesia of
the upper extremity" because of its ubiquitous application for upper
extremity surgery. The first percutaneous supraclavicular block was
performed by Kulenkampff in Germany in 1911. A few months after,
Hirschel described a method of brachial plexus with an axillary
approach. In 1928, Kulenkampff  and  Persky published  their
experiences with a thousand blocks  without  apparent major
complications.
? The block is  performed at  the level  of  the distal  trunks and origin of
the divisions, where the brachial plexus is confined to its smallest
surface area . The three trunks carry the entire sensory, motor, and
sympathetic innervation of the upper extremity, with the exception of
the uppermost part of the medial side of the arm (T2).
RELATIONSHIP OF BRACHIAL PLEXUS
Brachial plexus is contained within a fascial sheath. Subclavian
artery lies medial to plexus as they cross the 1st rib together. Note
location of phrenic nerve and vertebral artery.
LANDMARKS
Another important anatomic feature of the supraclavicular block is
the presence of the subclavian artery in front of the lower trunk and its
divisions . To increase the chance of blocking C8-T1 dermatomes it may
be beneficial to insert the needle in the proximity of the lower trunk and
make it the focal point of injection.
The sternocleidomastoid muscle inserts on the medial third of the
clavicle, the trapezius inserts on the lateral third, and the neurovascular
bundle passes underneath the middle third, which includes the midpoint
of the clavicle. During a supraclavicular block, the pleura potentially can
be breached either at the pleural dome (more likely) or through the first
intercostal space.  A practical knowledge of the anatomical position of the
pleura is important to decrease the risk of pneumothorax. The pleural
dome is  contained within the concavity of  the first  rib.  Because the first
rib crosses under the junction between the medial and middle thirds of the
clavicle  its path coincides with the insertion of the sternocleidomastoid
muscle, which inserts on the medial third of the clavicle. Therefore, the
lateral insertion of the sternocleidomastoid muscle on the clavicle can be
used as a landmark for the location of the first rib and of the lateral edge
of the dome of the pleura.
INDICATIONS
Surgeries involving the entire upper extremity distal to the
shoulder, including the upper arm and elbow as well as the forearm,
wrist, and hand.
APPROACHES TO SUPRACLAVICULAR BLOCK
1. The classical  approach  of  Kulenkampff.
2. The  subclavian  perivascular approach of Winnie and Collins.
3. The  modified  lateral paravascular approach of Moorthy.
For   supraclavicular  block  ,   the  patient   should    be   positioned
supine  and   neck  rotated  slightly  to  the contralateral side.
CLASSICAL APPROACH
In  the  midclavicular line , 1cm to the posterior to the clavicle  and
lateral   to  the  the subclavian  artery,   the needle  is  placed posteriorly,
medially and caudally until the brachial plexus is located.  If not found
the needle is walked along the clavicle.
COMPLICATIONS
Pnemothorax,   horner syndrome  , phrenic nerve palsy, nerve
injury (rare) , accidental intravenous injection of the local anesthetics.
COMPLICATIONS  OF  PERIPHERAL  NERVE BLOCK
? Systemic toxicity of the local anaesthetic:  The most common reason
being unintended intravascular injection. This risk can be minimised by
– Adhering to the recommended dosages
– Repeated aspiration and fractional injection
– Slow injection, observing and maintaining verbal contact with the
patient
? Nerve damage (extremely rare): this risk can be minimised by
– Trying to avoid paresthesia when inserting the needle.
– Correct use of a suitable nerve stimulator (? 0.3 – 0.5 mA/ 0.1 ms).
– The use of atraumatic needles.
? Hematoma: this can be prevented by avoiding blocks in the presence
of a clinically manifest coagulation disorder or  in a patient on treatment
with anticoagulations.
? Infection (especially when using continuous techniques): The most
sensitive indicator of infection is tenderness at the point of catheter entry
.This can be prevented by aseptic needle insertion and regular planned
checks of the catheter insertion site (at least once a day) and it requires
immediate removal of catheter.


Treatment of Systemic Local Anesthetic Toxicity
? Get help and call for 20% lipid emulsion.
? Perform airway management. Hyperventilate with 100% oxygen.
? Abolish the seizures
? Perform cardiopulmonary resuscitation
? Epinephrine-controversial; may have to use higher doses then
recommended in Advanced Cardiac Life Support (ACLS).
? Consider using vasopressin to support circulation
? Alert the nearest facility having cardiopulmonary bypass
capability.
? Perform lipid emulsion treatment (for a 70-kg adult patient):
? Bolus 1.5 mL/kg intravenously over 1 minute (about 100 mL)
? Continuous infusion 0.25 mL/kg per minute (about 500 mL over 30
minutes)
? Repeat bolus every 5 minutes for persistent cardiovascular
collapse.
? Double the infusion rate if blood pressure returns but remains low.
? Continue infusion for a minimum of 30 minutes.
PHARMACOLOGY
LOCAL ANESTHETICS
Local  anesthetics  are  drugs  used   to  prevent or relieve pain in
specific  regions  of   the  body  without  loss  of  consciousness.   Local
anesthetics  block  pain  sensation  by  blocking  nerve  conduction23.
MECHANISM OF ACTION
Local anesthetics exist as weak base, exist in a equilibrium between
unionised and ionised form23.
Nerve membranes are lipid membranes. Unionised  form  of   local
anesthetic   enters  the  nerve   membrane  .Here  the drug is ionised  and
it is the ionised form which blocks the  nerve  conduction, hence  local
anesthetic action  is strongly   dependent on  local PH.(alkaline –good,
acidic- bad).
A peripheral nerve contains several axon bundles called fascicles.
Endoneurium is the connective tissue that covers an individual nerve.
Perineurium is the connective tissue that covers each fascicle.
Epinerium is the connective tissue covering the entire nerve.
NERVE CONDUCTION PHYSIOLOGY
The neural membrane contains a voltage difference of +60 mV
(inner) to -90 mV (outer). At rest the neural membrane is impermeable to
Na+ ions, and selectively permeable to K+ ions. The Na+/K+ pump
maintains the ion gradient.
During an action potential, the nerve membrane switches its
permeability from K+ to Na+, changing the membrane potential from -90
to +60 mV (negative to positive) and back again.
Local anesthetics reversibly bind to the voltage-gated  Na+
channel, block      Na+influx, and  thus  block  action  potential  and
nerve conduction.
Small  unmyelinated  fibres , such as type C , that carry nociceptive
signals (pain) are more susceptible to local anesthetic block than the
larger fibres.
2.  Local  anesthetics  reversibly blocks  potassium channels  and  inhibit
propogation.
3.  Recent evidence  has highlighted  the diverse actions  of local
anesthetics. Not only do they block the sodium and potassium ion
channels, but also interact with G- coupled receptor proteins,
muscuranic receptor and endothelial  nitric oxide. Attachment of
local anesthetics  to G- coupled receptor protein  linked to
lysophosphatilic acid , it attenuates neutrophils ,macrophage and
monocyte function.
CLASSIFICATION OF LOCAL ANESTHETICS
AMIDES ESTERS
BUPIVACAINE BENZOCAINE
LIDOCAINE COCAINE
ETIDOCAINE PROCAINE
LEVOBUPIVACAINE TETRACAINES
MEPIVACAINE CHLORPROCAINE
PRILOCAINE
ROPIVACAINE
BUPIVACAINE
It   is   a  long   acting    amino amide  class of  local anesthetic.
It   is  a   member  of    the  series   of   n-  alkyl substituted pipecholyl
xylidines  first synthesised by  Ekenstam in 1957,  and   was used
clinically  in 1963.
Chemical name :   (2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-
carboxamide hydrochloride monohydrate.
PHYSICAL PROPERTIES
It appears as a white, crystalline powder or colourless crystals. It is
soluble in water, freely soluble in ethanol (96%), slightly soluble in
chloroform and in ether. Bupivacaine has  a  pKa  of  8.1  and  is more
lipid soluble than lignocaine.
CHEMICAL STRUCTURE
BUPIVACAINE
MECHANISM  OF ACTION :
Bupivacaine   reversibly  inhibit    the   peripheral  nerve   conduction  by
blocking voltage  gated  sodium  and  potassium channels .
PHARMACOLOGICAL  PROPERTIES
Molec
ular
weight
PKa Protein
binding
Partition
coeffient
Vd T1/2 clearance onset duration
288 8.1 95 28 1.0 210 8.3 moderate long
PHARMACOKINETICS
ABSORPTION:    All   Amides   show   a   biphasic   absorption  pattern  ,
with  an  initial  rapid phase followed by a  slow  phase.   Following the
rapid entry of local anesthetics into the venous circulation, pulmonary
extraction limits the concentrations of drug that reaches the systemic
circulation   for   the   distribution   to   the  coronary  and   cerebral
circulation.   For  bupivacaine  this  first  pass  pulmonary extraction  is
dose dependent, suggesting  that the uptake process rapidly becomes
saturated.
DISTRIBUTION :  More widely distributed in the tissue .
METABOLISM :  Liver
CLEARANCE: A small percentage of the bupivacaine is excreted
unchanged in        urine.
PLACENTAL  TRANSFER:    Protein  binding  determines  the  rate  and
diffusion of the local anesthetics across the placenta.  Bupivacaine ,
which is highly protein bound (about 95%) , has an umbilical vein /
maternal  arterial  ratio  of   0.3%.Acidosis  in  fetus  ,  as  occurs  during
prolonged labour , can result in accumulation of local anesthetics  in the
fetus by ion trapping24.
PHARMACODYNAMICS
Systemic absorption  of  local  anesthetics  produces effects on the
cardiovascular  and central nervous systems.
CARDIOVASCULAR SYSTEM
At blood concentrations achieved with normal therapeutic doses,
changes in cardiac conduction, excitability, refractoriness, contractility,
and peripheral vascular resistance are minimal. However, toxic blood
concentrations depress cardiac conduction and excitability, which may
lead to atrioventricular block, Ventricular arrhythmias, and cardiac arrest,
sometimes resulting in fatalities. In addition, myocardial contractility is
depressed and peripheral vasodilation occurs, leading to decreased
cardiac output and arterial blood pressure. Recent clinical reports and
animal research suggest that these cardiovascular changes are more likely
to occur after unintended intravascular injection of Bupivacaine.
Therefore, incremental dosing is necessary24.
CENTRAL  NERVOUS  SYSTEM
Following systemic absorption, local anesthetics can produce
central nervous system stimulation, depression, or both. Apparent central
nervous stimulation is manifested as restlessness, tremors progressing to
convulsions, followed by depression and coma progressing ultimately to
respiratory arrest. However, the local anesthetics have a primary
depressant effect on the medulla and on higher centers. The depressed
stage may occur without a prior excitation24.
INDICATIONS AND USES
Local   or   regional   anesthesia   or   analgesia   for   surgery,   oral
surgery procedures,  diagnostic  and  therapeutic  procedures, and for
obstetric procedures.
Routes of administration  Concentrations
Local infiltration 0.25%
Peripheral nerve  block 0.25% and 0.5%
Retro bulbar block 0.75%
Sympathetic block 0.25%
Lumbar epidural 0.25%,0.5%, and 0.75%( 0.75%
not for obstetric patients)
Caudal 0.25% and 0.5%
Bupivacaine  is manufactured in a  concentration of 0.25% or
0.5% for peripheral  nerve  block. It has a long duration of action, from 2
to 5 hours following a single epidural injection and up to 12 hours after
peripheral nerve blocks.  The onset of the blockade is slower than with
lignocaine, especially when anaesthetising large nerves.
When used in low concentrations (2.5 mg/mL or less) there is less
effect on motor nerve fibres and the duration of action is shorter. Low
concentrations may, however, be used with advantage for prolonged pain
relief, e.g. in labour or postoperatively. The plasma concentration of
bupivacaine depends upon the dose, the route of administration and the
vascularity of the injection site. The addition of a vasoconstrictor such as
adrenaline may decrease the rate of absorption and prolong the duration
of action.
Following injection of bupivacaine solutions for caudal, epidural or
peripheral nerve block, peak plasma levels of bupivacaine are reached
within 30 to 45 minutes and decline to insignificant concentrations during
the next 3 to 6 hours.
Intercostal blocks give the highest peak plasma concentration due
to rapid absorption (maximum plasma concentrations in the order of 1 to
4 mg/L after a 400 mg dose), while subcutaneous abdominal injections
give the lowest plasma concentrations.
Epidural and major plexus blocks are intermediate. In children
rapid absorption (plasma concentrations are in the order of 1 to 1.5 mg/L
after a dose of 3 mg/kg) is seen with caudal block. Absorption may be
slowed by the addition of adrenaline.
CONTRADICTIONS
1. Paracervical  block.
2. Allergy to amides group of drugs.
ADJUVANTS
Adjuvants are used in peripheral   nerve block to
1. Increase the duration of action.
2. Increase the onset of action.
3. Increase the quality and density of block.
4. Improve the overall analgesic effect.
WHAT HAS BEEN TRIED?
• Opioids (fentanyl4, sufentanil, morphine, buprenorphine5,
nalbuphine, tramadol3)
• Epinephrine2
• Sodium bicarbonate
• Steroids (dexamethasone, methylpred nisolone)
• ?-agonists (clonidine2,6, dexmedetomidine7)
• Midazolam
• Neostigmine
• Verapamil
• Magnesium
• Ketamine
• NSAIDS (ketorolac) and Lysine acetylsalicylic acid.
EPINEPHRINE
Vasoconstrictors are among   the  most common additives  to  local
anesthetic  solutions. The duration  of   a  local anesthetic is  proportional
to the duration  of  time  that  the  local  anesthetic  remains  in  contact
with a nerve;  therefore, a  vasoconstrictor  can  prolong  the  duration  by
decreasing vascular resorption.  Epinephrine  is  the  most  commonly
used   vasoconstrictor   in  combination  with  local  anesthetics24.
Epinephrine (adrenaline ), in concentration of 1 in 200,000 or 1 in
400,000 is sometimes  added  to  local  anesthetics  to reduce vascular
adsorption and potential  local anesthetic toxicity24.
Preparation of 1 in 200,000 epinephrine (adrenaline) involves
dilution  of   0.1 ml  of  1 in 1,000 ( 0.1 mg) epinephrine or  1ml  of 1in
10,000 (0.1 mg) to 20 ml volume of the local anesthetics ; 1in    400,000
dilutions are made  with  half of the above doses of adrenaline24.
Epinephrine  containing solutions contain a reducing agents,
sodium  metabisulphite  ,  to   prevent   oxidation  of   the   epinephrine  .In
addition , small amount of preservative and fungicide may be added.
The vasoactive  effect  of epinephrine (adrenaline) is greater with
the more lipid soluble amides .
DRUG DOSE WITH  EPINEPHRINE
LIGNOCAINE 3 mg/kg 7mg/kg
BUPIVACAINE 2.5mg/kg 3mg/kg
Epinephrine, by local vasoconstriction at the site of block
minimises the systemic absorption of bupivacaine. This reduces the risk
of bupivacaine toxicity.
DEXAMETHASONE
Dexamethasone is a longer acting , potent  and  highly  selective
glucocorticoid.   It   is   25  times   more   potent   than   cortisol   in   its
glucocorticoid  activity.
SYNTHESIS AND CHEMICAL STRUCTURE
The 16 ?- methyl prednisolone  acetate  is  dehydrated  to  form a
9,11-dehydro derivative.  This then reacts with a source of  hypobromite
such as basic  N-bromosuccinimide, to form the 9?-bromo-11?-hydrin
derivative which is then ring-closed to an epoxide.  A ring-opening
reaction   along with hydrogen fluoride in tetrahydrofuran  gives
dexamethasone.
                                                                                            Dexamethasone
MECHANISM OF ACTION
Steroids penetrate the   cells and bind to a high affinity cytoplasmic
receptor protein.   A  structure  change  occurs in the  steroid  receptor
complex  that  allows  its  migration into  nucleus and binding to specific
sites on the chromatin .This causes  transcription  of  specific  m-RNA
resulting of  protein synthesis.    This process takes  at least 30-60 min .
Effects  of  steroids  are  not immediate , and  once  appropriate  proteins
are  synthesized , effects  persist  much  longer than the steroid itself25.
The   glucocorticoid  receptor   is  very  widely  distributed  .Some
actions of  glucocorticoid  are  exerted  more   rapidly  but  mediated  by
a different  mechanism  not  involving  the  protein synthesis.
MAINTENANCE OF HOMEOSTASIS
        Permissive and protective effects of glucocorticoids are critical for
the maintenance of homeostasis during periods of stress. These actions of
gluco corticoids are complementary and permit the individual to effect an
appropriate stress response to stimuli and to maintain the homeostasis.
PERMISSIVE ACTIONS
         Permissive actions occur at a low physiological steroid
concentration and serve to prepare the individual for responding to stress.
These actions of glucocorticoids maintain the basal activity of the
hypothalamic pituitary axis by providing negative feedback and setting a
threshold for a response to stress25.
PROTECTIVE ACTIONS
Protective actions occur when high concentrations of steroids  exert
the anti –inflammatory   and   immune-supressive  effects .This response
prevents the host defence mechanisms that are activated during  stress.
Other important protective actions of glucocorticoids include redirection
of metabolism to meet energy needs during stress25.
PHARMACODYNAMICS
1. Carbohydrate metabolism
     Long term steroid  use   promotes glycogen deposition in the liver by
inducing hepatic glycogen  synthetase  and  promoting  gluconeogenesis.
They inhibit glucose utilisation by the peripheral tissue.  This along
with increased glucose release from the liver results  in  hyperglycemia,
resistance  to insulin , and a diabetes like state26.
2. Protein metabolism
        On chronic  use they cause protein breakdown and amino acid
mobilisation from peripheral tissues which is responsible for side effects
like muscle wasting , lympholysis  and  loss  of  osteoid  from  bone and
thinning of  skin. The amino acids which are mobilised are funnelled into
liver and are used up in gluconeogenesis; as a result excess urea is
produced leading to negative nitrogen balance. Glucocorticoids are thus
catabolic26.
3. Fat metabolism
       Long term use of glucocorticoids has a permissive action. They
promote lipolysis due to glucagon, growth hormone, adrenaline and
thyroxine. Further, cyclic AMP induced breakdown of triglycerides is
enhanced.  Fat depots in different areas respond differently and
redistribution of body fat occurs. Subcutaneous tissue over the extremities
loses fat which is deposited over the face, neck and shoulder causing
moon face, fish mouth, and buffalo hump26.
4. Calcium metabolism
          Long term steroids inhibit intestinal absorption and enhance renal
excretion of calcium. There is also loss of calcium from bone indirectly
due to loss of osteoid leading to negative  calcium balance .Spongy bones
like vertebrae, ribs are more  sensitive26.
5.Water  excretion
 Effect on water excretion is independent of action on sodium
transport. In adrenal insufficiency, the capacity to excrete a water load is
markedly reduced –such patients are prone to water intoxication from
intravenous infusions. Glucocorticoids also enhance secretory activity of
renal tubules26.
6. Cardiovascular system
Glucocorticoids restrict capillary permeability; maintain tone of
arterioles and myocardial contractility. They have a permissive effect on
the pressor action of adrenaline and angiotensin26.
They  also  play  a  permisive  role  in  the  development  of
hypertension; when considered for long term use , they should be used
cautiously  in hypertensive patients.
7. Central nervous system:
Mild euphoria is common with pharmacological doses of
glucocorticoids. This is a direct effect on brain , independent  of relief of
disease symptoms ; sometimes progresses  to cause increased  motor
activity   ,  anxiety ,  insomnia  or  depression26.
          Glucocorticoids also maintain the level of sensory perception and
normal level of excitability of neurones.  In high dose, glucocorticoids
lower the seizure threshold, hence caution is required when prescribed for
epileptics.
8. Skeletal muscles
            Optimal level of  corticosteriod is needed for normal muscular
activity  .  Weakness  occurs  in   both   hypo  and   hypercorticism,  but  the
causes are different. In hypocorticism, diminished work capacity and
weakness are primarily due to hypodynamic circulation. In
hypercorticism, excess mineralocorticoid action causing hypokalemia and
weakness26.
9. Gastrointestinal system
Secretion of gastric acid and pepsin is increased,  peptic ulcer may
be aggravated26.
10.  Lymphoid tissue and blood cells
                Glucocorticoids enhance the rate of destruction of  lymphoid
cells ; but in man the effect on normal lymphoid tissue is modest.
Glucocorticoids increase the number of  RBCs, decrease lymphocytes ,
eosinophils and basophils .This is not due to destruction of these cells but
due to   their sequestration in tissues. Blood counts come back to normal
after 24 hrs26.
11.Anti Inflammatory responses
        Mechanisms include  decreased  production  of interleukin-1,
interleukin-2, interleukin-3, interleukin-6, tumor necrosis factor,
granulocyte monocyte colony forming factor and gamma interferon.
This results in suppression of  fibroblast  proliferation  and  T-lymphocyte
chemotaxis  is interfered with  . The other effects include reduction of
increased capillary permeability, local exudation, cellular infiltration,
phagocytic activity and late responses like capillary proliferation,
collagen, and fibroblastic activity and ultimately scar formation. The
action is direct and local therefore topical use is possible26.
The most important  mechanism  appears  to  be  the  limitation  of
recruitment   of   inflammatory  cells   at   the   local  site   .Glucocorticoids
are  only  palliative  ,they  do  not  remove   the cause of inflammation.
12. Immunological and allergic response
Glucocorticoids   impair  immunological  competence. They
suppress  all   types   of   hypersensitisation   and   allergic   phenomenon  .
The clinical effect appears to  be  due  to suppression  of  recruitment  of
leukocytes at the site of contact with antigen and of inflammatory
response to immunological injury.
       They  cause  greater  suppression  of  Cell mediated immunity  in
which  T cells  are primarily  involved,  eg. Delayed  hypersensitivity
and  graft   rejection .  This  is  the basis  of   use  in autoimmune  diseases
and  organ transplantation. Factors involved may  be inhibition  of
Interleukin-1   release   from  macrophages  ,  inhibition   of   Interleukin-2
formation   and   action  .T  cells  proliferation   is   not   stimulated  .
Corticosteroids  also cause   suppression  of  natural  killer  cells26 .
PHARMOKINETICS
Bioavailability 80-90%
Protein binding 77%
Metabolism hepatic
Half-life 190  min
Excretion Urine(65%)
USES
1. POST OPERATIVE NAUSEA AND VOMITING (PONV)
Dexamethasone  along  with  ondansetron  prevents  postoperative
nausea and vomiting  only when administered near the beginning of
surgery, probably  by reducing the surgery induced inflammation due to
inhibition of prostaglandin synthesis  as for as 24 hours28.
2. DAY CARE SURGERY
 Steroids  decrease  post operative  nausea and vomiting ,
postoperative pain  , by decreasing  prostaglandins  and  increasing  the
level  of endorphins28.
3. ANAPHYLACTIC AND ALLERGIC REACTIONS
           Steroids because of their delayed onset are not the drug of choice
in treating  anaphylactic  reactions . They are usually used as an adjuvant
to adrenaline. Manifestations of allergic diseases that are of limited
duration like hayfever , serum sickness, urticaria, contact dermatitis, drug
reactions, bee stings, and  angioneurotic edema can be suppressed by
adequate doses of cortisteroids. Topical steroids having the potent anti –
inflammatory effects are the main stay of allergic therapy28,29,30.
These medications interfere with the inflammatory response and
multiple aspects of allergic cascade. Corticosteroids work by inhibiting
the production of inflammatory cytokines and chemokines, thus
decreasing inflammation and cellular edema, and cellular recruitment to
site of disease.
4.SEPTIC SHOCK  AND SEVERE SEPSIS
Patient with sepsis have an unrecognised adrenal insuffiency with an
incidence  of as high as 28%.  Steroid therapy is associated with success
in the withdrawal of vasopressors28.
5.POSTOPERATIVE  ANALGESIA
Glucocorticoids inhibit the phospholipase enzyme that is necessary
for the inflammatory chain reaction along both the cyclooxygenase and
lipooxygenase pathways .As a result, glucocorticoids may be  effective in
decreasing postoperative pain . It has been shown that dexamethasone
given intravenously before induction of anaesthesia for anorectal surgery
was associated with shortened time to discharge from ambulatory
surgery28.
              Routes of administration of steroids include parenteral, nerve
blocks and central neuraxial blockade. Mode of analgesia is ill defined
but thought to be due to   their anti-inflammatory action which decreases
the inflammatory mediators responsible for pain sensation. They also
increase endorphins and thus cause mood elevation.
6.PERIOPERATIVE  REPLACEMENT  THERAPY
One  of  the  important  component  of  stress response  in our body
is increase  in  the circulating levels  of  cortisol  in  response  to  surgical
stimulus  .This response  is essential   to  avoid  metabolic , electrolyte ,
fluid balance  and  hemodynamic instability.   It is necessary  in  patients
with    hypo  adrenocortism   or   in   patients  with   present   or   previous
history of  steroid intake. The dose and duration remains controversial.
Patients taking steroids for transplant procedures should receive the same
dose of steroids with no extra dose of steroids required during the
perioperative period. There is no fixed protocol for steroid replacement
therapy28,29.
7. ANTI INFLAMMATORY AND HYPER REACTIVE AIRWAY
      Steroids have anti-inflammatory actions at higher doses.
Perioperative uses  include  hyper-reactive  airways due to  asthma,
foreign  body,  and  trauma , anaphylactic reactions like drug allergies,
blood transfusion reactions and  transplantation of  solid organs28,29.
8.CEREBRAL EDEMA
Corticosteroids in larger doses are of value in the reduction  or
prevention of cerebral edema and the resulting  increases in intracranial
pressure that may accompany tumors and metastatic lesions in the brain
.Dexamethasone, with its minimal mineralocorticoid activity, is
frequently used to decrease cerebral edema and associated increase in
intracranial pressure28,29.
9.POST INTUBATION LARYNGEAL EDEMA
           Dexamethasone, 0.1-0.2 mg/kg intravenously can be administered
for the treatment of post intubation  laryngeal edema .But the efficacy of
steroids for this condition has not been confirmed28.
10.RESPIRATORY DISTRESS SYNDROME
              Administration of steroids at least 24 hours before delivery
decreases the incidences and severity of respiratory distress syndrome in
neonates born between 24 and 34 weeks gestation. Dexamethasone
improves the pulmonary and neurodevelopment outcome of a low birth
weight infant at  risk of  bronchopulmonary  dysplasia.28
11.OTHERS
 To test adrenal pituitary axis function, congenital adrenal
hyperplasia, aspiration pneumonitis, lumbar disc disease,
immunosupression, arthritis, collagen vascular disease, cutaneous
disorders, ocular inflammation28.
DEXAMETHASONE    AS    ANALGESIC
 Why dexamethasone   would prolong   regional anaesthesia is of
much discussion?
The  mechanism of  action  of  corticosteriods    producing  analgesia
is still controversial.    Their effects are suspected to be mediated by anti
inflammatory and immuno supressive   effects.
There  are    some  authors  who  believe  that  the  nerve  block
prolonging effect of dexamethasone is due to its local action. . Steriods
produce analgesia by blocking the transmission in nociceptive   C-fibres
and    thus    supressing   the  ectopic  neuronal  discharge  .    For  example,
local application of methylprednisolone block the transmision of   C
fibres but not the  alpha and Beta  fibres.
This effect is reversible, probabaly suggesting a direct membrane
effect.  Steriods may  bring   this  effect  by  altering  the function of the
potassium  channels   in   the   excitable  neurons.  The  analgesic  effect  of
dexamethasone  may  be  related  to  its  local  action.   It   should   be
emphasized that  blockade  is  not produced  by  corticosteriod  alone  for
peripheral nerve blocks, but  these  steroids  may  potentiate  the  effect
of  local  anesthetic drugs in the modulation of the potassium channels in
the excitable neuron.
MATERIALS AND METHODS
The study was carried out in the Department of Anesthesiology,
ESIC  MC  AND  PGIMSR,   K.  K  Nagar,  Chennai  from  March  2013  to
AUGUST 2014.
STUDY DESIGN: - Prospective randomized control trial
PARTICIPANTS
Participants were recruited from the patients posted for upper limb
surgeries in ESIC MC AND  PGIMSR .The protocol was approved by the
Ethical committee of ESIC MC AND  PGIMSR. After departmental
approval and obtaining written informed consent from the patients,
American Society of Anaesthesiologist (ASA) physical status I or II
patients of either sex, aged 18-60 years  scheduled  for  elective  or
emergency  surgeries of  the upper limb under  supraclavicular brachial
plexus block were included in this study.
INCLUSION CRITERIA
All patients undergoing upper limb surgeries (arm, forearm, hand
surgeries) under supraclavicular block between 18 to 60 years of age and
belonging to  ASA  physical status  I or  II were included in this study.
EXCLUSION CRITERIA
? Any bleeding disorder and patient on anticoagulants
? Contralateral lung injury and rib fracture
? Pre-existing neuropathy involving the surgical limb
? Local infection at the injection site
? History of allergy to local anaesthetic
? Patients with a history of peptic ulcer disease, hepatic or renal
failure (contraindication to steroids)
? Pregnant women
? Systemic use of corticosteroids for 2 weeks or longer within 6
months of surgery
 The patients were explained about the study in detail and written
informed consent was taken.
BASELINE EVALUATION
The initial evaluation consisted of detailed history and general
physical and systemic examination. Data recorded include information on
age, weight, height, body mass index (BMI) and blood pressure
measurement.
LABARATORY METHODS
Baseline    Laboratory  investigations     included    Complete
hemogram ,  Blood urea nitrogen  ,  Blood sugar ,   liver function tests ,
chest  X-ray  and    Electrocardiogram.
INTERVENTION
RANDOMIZATION : The      patients      were      then     randomly
assigned to    either    the       group D (study group)    and    the  group B
(control  group)   as   determined  by  the  slips  in  box method.
All   patients   included   in   the    study    on  arrival    to    the
operating  room   had   an  18  G  intravenous  (IV)  line   started   on  the
contralateral  arm  and  standard   monitors   like   pulse oximetry,    non
invasive  blood pressure (NIBP)  and  electrocardiogram(ECG)  were
attached.  Baseline  pulse rate  ,  blood pressure  , oxygen saturation  were
recorded.
LOCAL ANESTHETIC PREPARATION
Local anesthetics  drugs are taken  with the use  of 20 ml syringes
and  kept  in  sterile  bowl .
GROUP D
                DRUGS          TOTAL VOLUME  -28 ml
  BUPIVACAINE  0.5% with
1.25ml of 1 in 10000
epinephrine
25 ml
DEXAMETHASONE  8mg 2 ml
   DISTILLED WATER 1  ml
 GROUP B
                       DRUG   TOTAL VOLUME – 28 ml
          BUPIVACAINE   0.5%
with 1.25ml of 1 in 10000
epinephrine
                  25 ml
       DISTILLED WATER                   3 ml
Oxygen is administered at the rate of   4L/min through face mask.
Midazolam 1mg iv given. A set containing  nerve stimulator, insulated 50
mm needle,  ECG electrode ,Two 20 ml syringes,   Skin marker pencil,
one tuberculin syringe of 1 ml,    one stainless sterile bowl   for    local
anesthetic drugs  preparation , and sterile gauze pieces.  Supraclavicular
block  by a classical approach was given using  a nerve stimulator.
TECHNIQUE
Supraclavicular block –Classical approach ( nerve-stimulator technique)
1.Patient was placed in a dorsal recumbent position without  a   pillow
with  arms  at  his / her sides  and  head   turned   to   side opposite  to
the one  being  blocked. A  small pad was placed below bilateral
shoulders.
The    patient  was  then  asked  to  lower  the  shoulders  and  flex  the
elbow, so that the forearm   rests on his/her lap. The wrist was supinated
so the palm of the hand faces the patient’s face.
2. Part of the neck was aseptically cleaned and draped.
 3. The operator stood on the side to be blocked so for a left side block
the palpation was done  with the left hand and the needle was
manipulated with the right and vice versa.
4. The  lateral (posterior) border  of  the sternocleidomastoid (SCM)
muscle was  identified and followed distally to the point where it met the
clavicle. The point of needle entrance was about 1 in (2.5 cm) lateral to
the insertion of the SCM in the clavicle or one “thumb breadth” lateral to
the  SCM.  Palpation  of  the  subclavian  artery  at  this  site  confirms  the
landmark. The palpating index finger was placed at this site.
5.   Local infiltration with 1ml of 2%  lignocaine  was  given.
6.  An insulated needle of length 50 mm was used to perform this
technique. The needle was connected to nerve locator by the electrodes
and was properly grounded with the help of ECG lead. The stimulation is
started with an intensity of 2.0 mA and a  pulse width of 100 ?s. Once the
desired response is obtained i.e a muscle twitch of the fingers that is
clearly visible, the current was gradually decreased upto 0.6mA. If the
response is obtained at 0.4mA  also, then the needle  was repositioned
again  so as to get  response at 0.6mA  but  not  at 0.4mA.
 7.  If we did not get an  adequate response or if repositioning of the
needle is necessary, the needle was withdrawn and the penetration  angle
is adjusted in the antero-posterior  plane.
As a goal we aimed to elicit an isolated muscle twitch in all fingers
either in flexion or extension.
Wrist flexion and extension of the fingers was taken as acceptable
responses and the current gradually reduced to between 0.2 to 0.5 mA   .
The total volume of the anasthetic solution was injected at an incremental
dose of 5ml each, preceded by negative aspiration.  3-min massage was
performed to facilitate an even drug distribution.

FLEXION AT ELBOW  (Musculocutaneous nerve)
WRIST FLEXION AND FINGER FLEXION (median nerve)
ULNAR DEVIATION OF WRIST AND THUMB
ADDUCTION(ulnar nerve)
WRIST EXTENSION AND THUMB
ABDUCTION(radial nerve)
Vital parameters were observed throughout the procedure every 15
minutes as usual and recorded.
BLOCK EVALUATION
Sensory   block  was  assessed  by  pinprick method  using  a end
of a 27 gauge needle  at  0, 2, 4, 6, 8 and every 2 minutes till  30 minutes
in the median ulnar, radial ,  musculocutaneous  nerve  distribution.
GRADES OF SENSORY BLOCKADE17:
Grade 0: Sharp pin felt.
Grade 1: Analgesia, dull sensation felt
    Grade 2: Anaesthesia, no sensation felt
The onset time of sensory blockade was defined as the time
interval between the end of local anasthetic injection and loss of sensation
to pin prick (grade 1).
MOTOR BLOCK17
Motor block was measured at 0, 5, 10 ,15 ,20 ,25,and 30  minutes  by
assessing
1.extension of elbow and wrist (radial nerve)
2.opposition of the thumb and index finger(median nerve)
3.opposition of the thumb and small finger(ulnar nerve)
4.flexion at the elbow (musculocutaneous nerve)
MOTOR BLOCK- MODIFIED BROMAGE SCALE.
Grade 0: Normal motor function with full flexion and extension of
elbow, wrist and fingers.
Grade 1: Decreased motor strength with ability to move the fingers
only.
Grade 2: Complete motor block with inability to move the fingers.
 The onset time of motor blockade was defined as the time interval
between the end of local anasthetic injection and paresis (grade 1)  in  the
distributions of all peripheral nerves respectively.
The surgery was allowed to proceed when  complete  anasthesia is
achieved. The duration of surgery in each case was noted.
       The duration of analgesia was defined as the time between
onset  of  analgesia   to   first     pain    perception    by    patient.      The
duration of analgesia was noted  according  to  the visual analogue score
(VAS)  for  pain  for   every hour  for  first 10  hours and  then   every
second   hourly till 24 hours.
• When the patients began to experience the worst pain (VAS =>4),
it is considered that analgesic action of the drugs is terminated and
rescue analgesic (Intramuscular Diclofenac 1 mg/kg)  given . The
duration of analgesia was noted for every patient.
         PATIENT  FLOW  CHART
ASSESSMENT CLINIC      ASA I  AND  ASA II   ( 18-60 YEARS )
 INFORMED   CONSENT VISUAL ANALOGUE
SCORE EXPLAINED
ON THE DAY OF SURGERY         80 PATIENTS( upper limb surgery)
    RANDOMISATION                                SLIPS IN BOX
                                                                      METHOD
                                           GROUP D
                                          GROUP B
Patient shifted inside the operation theatre by the trained
personel with a trolley .
INSIDE THE THEATRE                        WHO CHECK LIST
MONITORS CONNECTED
Intravenous line started with 18 G  needle
Airway cart and rescue measures kept
 Group D                                                           Group B
Bupivacaine 0.5% with 1.25ml        Bupivacaine 0.5% with 1.25ml
         of 1 in 10000 Epinephrine – 25ml        of 1 in 10000 Epinephrine – 25ml
Dexamethasone – 8mg Distilled water -3 ml
Distilled Water- 1ml
SUPRACLAVICULAR  BLOCK – CLASSICAL METHOD
                                  (Nerve  stimulator )
Onset of motor block        onset of sensory block
 (modified Bromage scale)                              ( pin prick method )
                  Vital parameters  monitored every 15 minutes
                              Duration of surgery noted
POSTOPERATIVE PERIOD      Patient followed up with VAS
VAS > 4
Rescue analgesia                          Diclofenac injection i.m
DURATION OF ANALGESIA NOTED
OBSERVATION AND RESULTS
Discrete categorical data were presented as n (%); continuous data
were given as mean±SD. For normally distributed data, t-test was applied
for  comparison  between  two  groups.   For  experimental  data  (onset  of
sensory and motor blockade, duration of analgesia and visual analogue
score), independent t-test was applied for comparison between two
groups.For multiple comparisons (between different time intervals) One
Way ANOVA test was applied. All statistical tests were two-sided and
performed at a significance level of ?=0.05. Analyses were conducted
using SPSS for Windows (version 15.0; SPSS Inc., Chicago, IL, USA).
A total of eighty patients who were given supraclavicular block for
various upper limb surgeries completed this randomized controlled study.
Of these 80 patients,40 were in group D (study group) and 40 were in
group  B (control group).
TABLE1
COMPARISON OF BASELINE DATA BETWEEN
THE TWO GROUPS
VARIABLE
GROUP B
n=40
Group D
n=40 p value
Age in years
(Mean±S.D) 34.6 ± 11.44 37.45 ± 11.71 0.27
Weight in kg
(Mean±S.D) 65.15 ± 5.47 65.9 ± 5.11 0.53
Height in cms
(Mean±S.D) 166 ± 5.65 166.52 ± 8.06 0.71
BMI in kg/m2
(Mean±S.D) 23.6 ± 1.31 23.78 ± 1.24 0.63
Sex distribution
a. Males
b. Females
35
05
33
07 0.54
ASA
a. I
b. II
26
14
30
10 0.34
Level of surgery
a. Elbow and
above elbow
b. Forearm
c. Hand
10
25
05
11
19
10
0.51
Type of surgery
a. Elective
b. Emergency
37
03
32
08 0.11
BMI-body mass index;ASA-American society of anaesthesiologist.
FIGURE 1
COMPARISON OF AGE BETWEEN THE TWO GROUPS
FIGURE 2
COMPARISON OF WEIGHT BETWEEN THE TWO GROUPS
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FIGURE 3
COMPARISON OF HEIGHT BETWEEN THE
TWO GROUPS
FIGURE 4
COMPARISON OF BMI BETWEEN
THE TWO GROUPS
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FIGURE 5
SEX DISTRIBUTION IN THE TWO GROUPS
FIGURE 6
COMPARISON OF ASA CLASS BETWEEN
THE TWO GROUPS
In figure 6:  I  -ASAI,  II- ASAII
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FIGURE 7
COMPARISON OF LEVEL OF SURGERY IN  2 GROUPS
In figure 7:
                        I  -   Elbow and above elbow surgery
                        II -    Fore arm surgery
                       III –   Hand  surgery
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FIGURE 8
COMPARISON OF TYPE OF SURGERY BETWEEEN
THE TWO GROUPS
 Table  1    and    Figure  1-  8,    clearly  demonstrates   that   all  the
baseline   data  were  comparable between the two groups of
patients.(p>0.05).
TABLE 2
COMPARISON OF ONSET OF MOTOR AND SENSORY
BLOCKADE
GROUP B
(Mean±S.D)
GROUP D
(Mean±S.D)
p VALUE
ONSET OF MOTOR
BLOCKADE (MIN)
11.5±3.43 7.5±3.2 < 0.0001*
ONSET OF SENSORY
BLOCKADE(MIN)
13.6±6 4.2±0.99 < 0.0001*
*highly significant (p<0.0001)
FIGURE 9
COMPARISON OF ONSET OF MOTOR BLOCKADE BETWEEN
THE TWO GROUPS
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FIGURE 10
COMPARISON OF ONSET OF SENSORY BLOCKADE OF
THE TWO GROUPS.
Table 2 and figure 9 and 10 show the comparison between the two
groups with respect to onset of sensory and motor blockade. There was a
significantly earlier onset (p<0.0001) of both sensory and motor blockade
in the group D(study  group) as compared to group B (control group) .
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TABLE 3
COMPARISON OF PULSE RATE OF THE TWO GROUPS AT
DIFFERENT TIME INTERVALS OF THE STUDY
Groups Pre op 0min
15
min
30
min
45
min
60
min
p
value
Group D
(beats
/min)
87.85 ±
5.36
86.58
± 5.82
87.4
±8.73
85.2 ±
8.2
85.18 ±
7.93
86.7±
8.6 0.511
Group B
(beats/min)
91.9 ±
11.49
95.18
± 7.71
94.25 ±
7.12
94.5 ±
7.36
93.15 ±
6.9
91.5
±7.52 0.257
FIGURE 11
 COMPARISON OF PULSE RATE OF THE TWO GROUPS AT
DIFFERENT TIME INTERVALS OF THE STUDY
TABLE 4
COMPARISON OF SYSTOLIC BLOOD PRESSURE
OF THE TWO GROUPS AT DIFFERENT TIME
INTERVALS OF THE STUDY.
Groups Pre op 0 min 15 min 30 min 45 min 60 min pvalue
Group D
(mm/Hg)
119.43
±
13.22
119.15
±
10.97
119.83
± 9.75
118.03
±
10.14
121.43 ±
10.34
118.1±10.
04
0.746
Group B
(mm/Hg)
118.4
±
13.21
121.83
±
10.89
122.4
±
10.79
121.05
± 9.54
119.15 ±
9.32
116.22±9.
09
0.083
FIGURE 12
COMPARISON OF SYSTOLIC BLOOD PRESSURE THE TWO
GROUPS AT DIFFERENT TIME INTERVALS OF THE STUDY
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TABLE 5
COMPARISON OF DIASTOLIC BLOOD PRESSURE OF THE
TWO GROUPS AT DIFFERENT TIME INTERVALS OF THE
STUDY
Groups Pre op 0 min 15min
30
min
45
min 60 min
p
value
Group D
(mm/Hg)
74.13
± 7.13
72.8 ±
4.63
72.53
± 4.56
72.45
± 3.57
73 ±
3.54
71.65
± 3.92
0.305
Group B
(mm/Hg)
73.85
± 7.36
75.18
± 6.88
73.03
± 4.05
72.93
±  3.88
72.38
± 4.84
72.8
±4.61
0.230
FIGURE 13
COMPARISON OF DIASTOLIC BLOOD PRESSURE OF THE
TWO GROUPS AT DIFFERENT TIME INTERVALS OF THE
STUDY
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TABLE 6
COMPARISON OF MEAN ARTERIAL PRESSURE (MAP) OF
THE TWO GROUPS AT DIFFERENT TIME INTERVALS OF
THE STUDY
Groups Preop 0 min 15 min 30 min 45 min 60 min
p
value
Group B
(mm/Hg)
89.2 ±
8.08
88.23
± 5,27
88.25
± 4.71
87.75
± 4.49
89.13
± 4.67
87.13
± 4.82
0.452
Group D
(mm/Hg)
88.7 ±
8.15
90.73
± 6.83
89.52
± 5.04
88.97
± 3.86
87.97
± 5.78
87.27
± 3.64
0.126
FIGURE 14
COMPARISON OF MEAN ARTERIAL PRESSURE (MAP) OF
THE TWO GROUPS AT DIFFERENT TIME INTERVALS OF
THE STUDY
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The two groups were comparable pre operatively and at  baseline
with respect to pulse rate,and blood pressure(systolic, diastolic and mean
arterial pressure)  and there was no significant change in these parameters
at 15,30,45 and 60 min after the block as shown in   Table 3-6 and figure
10-14 .
FIGURE 15
COMPARISON OF DURATION OF SURGERY BETWEEN THE
TWO GROUPS
As shown in figure 15, there was no significant difference in the
duration of the surgery between the two groups ( 3.70 ± 1.28 in group D
Vs 3.23 ± 0.99 in group B, p=0.22)
2.71
3.23
Duration of Surgery(hrs)
Group
D
TABLE 7
COMPARISON OF DURATION OF ANALGESIA BETWEEN
THE TWO   GROUPS.
GROUPS
DURATION OF ANALGESIA
(HOURS)
GROUP D
                18.97 ±   2.67
GROUP B
                   9.10  ±   1.79
FIGURE 16
COMPARISON OF DURATION OF ANALGESIA BETWEEN
TWO GROUPS
As shown in Table 7 figure 16, there was  a significant
prolongation in the duration of analgesia in group D as compared to
group B ( 18.90   ± 2.67  vs   9.10± 1.79 ,p<0.001)
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hr
TABLE 8
COMPARISON OF VAS SCORES OF THE TWO GROUPS
VAS scores
Group D
(Mean ± SD)
Group B
(Mean ± SD)
p value
Time to reach
V2
(hrs)
16.23 ± 2.99 7.93  ± 1.36 <0.001*
Time to reach
V4
(hrs)
18.4 ± 2.8 9.05 ± 1.69 <0.001*
*highly significant (p<0.001)
  V2 – vas score of 2,      V4  - vas score of 4.
FIGURE 17
V2(time to reach vas score of 2)
 V4( time to reach vas score of 4)
As  shown  in  table  8  and  figure  17,   there   was  a  significant
prolongation  of  the  time  to  reach  VAS  score  of  2   in  group  D  as
compared to group B(16.23 ± 2.99 hrs in group D vs 7.93  ± 1.36 hrs in
group B, p<0.001) . Similarly, the time to reach VAS scores of 4 was also
significantly prolonged in group D as compared to group B(18.4 ± 2.8 hrs
vs 9.05 ± 1.69 hrs,p<0.001  .The analgesia lasted for   a  longer  time  in
the dexamethasone group  compared to bupivacaine group.
DISCUSSION
Eighty  patients  under  going  upper limb surgery were randomised
into two groups as dexamethasone group (group D)  and  Bupivacaine
group (group B) by slips in box method .All the baseline data were
comparable between the two groups .Thus bias in our study is excluded.
In our study, we used dexamethasone as an adjuvant to local
anesthetics. The primary outcomes assessed were onset of sensory and
motor  blockade and the duration of   analgesia.
Sensory blockade in our study and control group  were 4.2±0.99
min and 13.6± 60 min respectively while  the mean onset of motor
blockade in group D and group B  was 7.5±3.2 and 11.5±3.43 minutes
respectively. Both these data were statistically  significant( p<0.0001).So
our study showed that there was a significant early onset of sensory and
motor blockade in the study group as compared to the control group.
This  results  were  in concordance  to the findings of  a study by
Islam  et  al.  who   reported    a  significant  early    onset   of   sensory
blockade (9.89±1.97 min vs 11.64±2.19 min,p<0.05) and motor  blockade
( 11.09±2.19 minutes Vs 13.32±9.8 min,p<0.05) in the study group  when
to the compared  to the   control group .
In another often quoted study, Shreshtha et al found a significant
early onset of sensory blockade  in the steroid plus local anesthetic group
as compared to the local anesthetic only group (14.50±2.10 min Vs
18.15±4.25 min).
They had further compared tramadol and dexamethasone as an
additive to bupivacaine  in supraclavicular block and showed a significant
earlier onset of sensory blockade in the dexamethasone group
(16.76±2.34 Vs 18.47±2.03,p=0.004) .  This early onset of  blockade
with   dexamethasone   may  be   due   to   synergistic   action   with    local
anesthetic  drug   in   blocking  the nerve  fibres.
            The duration of analgesia is one of the primary outcomes that has
been studied in all these studies where dexamethasone has been studied
as an aduvant to local anethetics. In the study by Shreshtha et al
comparing the analgesic efficacy of dexamethasine with tramadol, the
duration of analgesia  had significantly prolonged  in dexamethasone
group (1028.17±194.51  min vs453.17±72.87 min,p<0.001) .
Yadav et al  in  a double  blinded  study  studied the effectiveness
of adding dexamethasone or neostigmine  to local anesthetic and showed
that the duration of analgesia was maximum  in the  dexamethasone
group (454.2±110.7 Vs 225.7± 53.3 Vs 176.5± 53.5,p<0.001) .
Parrington  et  al   in  a    randomised   controlled  study   found  that
addition of dexamethasone 8 mg to  mepivacaine  in supraclavicular
block  dramatically increased the mean duration of analgesia to about
332minutes as compared to 228 min  in the control group.  Islam et al
also showed similar prolongation in the duration of analgesia on addition
of dexamethasone to local anesthesia(11.87 ±0.53 vs 3.43± 0.49,p<0.001)
Pathak et al  did a  comparative study on supraclavicular block with
or without dexamethasone to local anesthetic and   showed that the
duration  of analgesia was prolonged to 834 ± 78.1 in the study group as
compared to  276 ± 38.73 minutes  in the control group .
Our study was in concordance with all these previous studies in the
fact that the analgesia duration was significantly prolonged in the study
group to 18.90   ± 2.67  min as compared to   9.10± 1.79 min  in the
control group.(p<0.001).
During  this  study ,  two  patients   from  the  study  group  showed
24 hours of   analgesia   which  may  not   be  statistically  signicant, but
shows some clinical   relevance  to  investigate  further.
SUMMARY
Regional anesthesia  is preferred to general anesthesia for upper
limb  procedures  since  they  provide   excellent  analgesia   which  extends
into the   postoperative period.
This study compared the analgesic efficacy of dexamethasone as an
adjuvant to  bupivacaine in supraclavicular brachial  plexus block.  This
is a  prospective randomised controlled  study .In this study, eighty
patients were  randomly  divided  into two groups as group D (Study
group) and group B (control group).  The study group received 25 ml of
0.5% bupivacaine with 1.25ml of 1 in 10000 epinephrine and 8mg of
dexamethasone. The control group received 25 ml of 0.5% bupivacaine
with 1.25ml of 1 in 10000 epinephrine. Total volume of the local
anesthetic was made to 28 ml by adding distilled water.
Epinephrine  was added  to decrease  sysytemic absorption and to
reduce  local anesthetic  toxicity .Supraclavicular block given with nerve
stimular technique by classical approach. Onset of motor and sensory
block and duration of analgesia were observed. In this study ,mean onset
of motor block were 7.5±3.2 minutes in the  dexamethasone  group and
11.5±3.43 minutes in the Bupivacaine  group respectively.
The mean onset of sensory block was 4.2±0.99 minutes  in the
dexamethasone group and 13.6±6 minutes  in  the bupivacaine  group
.Both the results show early onset of motor and sensory block in the study
group  which was statistically significant (p<0.0001). Mean duration of
analgesia was 18.9±2.68in the study group .The duration of analgesia was
significantly longer and  VAS scores were lower  in the dexamethasone
group compared to the Bupivacaine  group.
CONCLUSION
From this study it is concluded that,
Dexamethasone in the dose of 8mg given as an adjuvant in
supraclavicular block  along with  Bupivacaine and   epinephrine   results
in early onset of motor and sensory block . The duration of analgesia is
also  significantly prolonged.  The  prolonged postoperative pain relief
helps  in   early  mobilisation   and   there by  improving   physical  and
psychological   wellbeing    of  the   patient .
  This   dose   is  optimal   in   that   it   does   not   cause   any    side
effects at  the  same  time it provides excellent  intraoperative and
postoperative analgesia.
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PATIENT CONSENT FORM
Study title
A prospective Randomized controlled  study comparing  the Analgesic
efficacy of Dexamethasone when added to Bupivacaine  in supraclavicular brachial
plexus block for upper limb surgeries .
Study centre  : ESI – PGIMSR, K.K.NAGAR, CHENNAI -78
 Participant name : Age:                         Sex:
I confirm that I have understood the purpose of procedure for the
above  study  .  I  have  the  opportunity  to  ask  the  question  and  all  my
questions and doubts have been answered to my satisfaction.
I have been explained about the pitfall in the procedure.  I have
been explained about the safety,advantage and disadvantage of the
technique. I understand that my participation in the study is voluntary and
that I am free to withdraw at anytime without giving any reason.
I understand that investigator ,regulatory authorities and the ethics
committee will not need my permission to look at my health records both
in respect to current study and any further research that may be conducted
in relation to it, even if I withdraw from the study . I understand that my
identity will not be revealed in any information released to third parties or
published , unless as required under the law . I agree not to restrict the use
of any data or results that arise from the study.
I understand that  that I will receive drugs to prolong the duration
of analgesia using dexamethasone in supraclavicular brachial plexsus
block.  I have been explained that the anesthetic technique is a standard
and approved technique. This may help in future research in the field of
anesthesia. I consent to undergo this procedure
Insurance No:
Date:                                              Signature / thumb impression of
PROFORMA
Name of the patient:
Age:
Sex: Wt:
Insurance No: OT:
Diagnosis: Duration of Procedure:
Surgeon: Anaesthetist
 PREOPERATIVE DETAILS
ASA Grade Remarks:
vitals
BP Pulse
rate
Resp.
rate
SpO2 Temp ECG Xray
Hb RBS RFT LFT Others
 PROFORMA
BASELINE
DATA
GROUP - D GROUP -B P VALUE
AGE
SEX
WEIGHT
HEIGHT
BMI
LEVEL OF
SURGERY
I-elbow and
above elbow
II –Forearm
III - Hand
TYPE OF
SURGERY
I-Elective
II-Emergency
ASA I
         II
 INTRAOPERATIVE DETAILS:
 EXPERIMENTAL PARAMETERS
GROUP D GROUP B P VALUE
Onset of sensory
blockade
Onset of motor
blockade
Duration of
Analgesia
VITAL PARAMETERS:
1.PULSE RATE
Groups Pre op 0 min 15 min 30 min 45 min 60min P value
Group
D
Group
B
2.SYSTOLIC BP
Groups Pre op 0 min 15 min 30 min 45 min 60 min P value
Group
D
Group B
3.DIASTOLIC BP
Groups Pre
op
O min 15 min 30 min 45 min 60 min  P
value
Group D
Group B
4. MEAN ARTERIAL PRESSURE
Groups Preop 0 min 15min 30
min
45
min
60
min
P
values
Group D
Group B
POSTOPERATIVE  PERIOD
VAS SCORES
GROUPS 1 st HR 2 ndHR 3 rd HR 4 th HR 5 th HR
GROUP D
GROUP B
GROUPS 6 th HR  7 th HR 8 th HR 9 th HR 10 th HR
GROUP D
GROUP B
GROUPS  12 th HR 14 th HR 16 th HR 18 th HR 20 th HR 22 th HR 24 th HR
GROUP D
GROUP B
SIGNATURE OF INVESTIGATOR             SIGNATURE OF THE
PARTICIPANT                                               WITNESS
NAME GROUP AGE SEX IP NO WEIGHT HEIGHT BMI ASALEVEL OF SURGERYTYPE OF SURGERYPR-pr SYS-pr DIA-pr MAP-pr SPO2-pr ON_MB ON_SB PR-0 SYS-0 DIA-0 MAP-0 SPO2-0 PR-15SYS-15DIA-15 MAP-15
mohanaraman D 47 M 51-11933469 78 172 26.3656 I II I 88 138 80 99.3 100 5 4 72 130 80 96.7 99 72 133 74 93.7
Manikandan B 21 M 51-60474674 71 169 24.85907 I II I 110 124 78 93.3333333 100 15 12 104 124 75 91.3333333 100 104 122 72 88.667
Alaguraja D 22 M 51-21870502 54 160 21.09375 II II I 98 138 88 105 99 5 4 90 132 80 97.3 100 90 130 80 96.7
Balakumar D 60 M 51-21605169 69 170 23.87543 II II II 78 102 70 80.7 100 5 4 86 106 70 82 100 82 112 72 85.3
 Nagarajan B 41 M 51-20451200 78 176 25.18079 I II I 106 144 96 112 100 15 18 104 140 74 96 100 102 142 72 95.333
Kokila D 37 F 51-22836072 54 156 22.18935 I I I 102 132 72 92 100 5 4 92 128 68 87.3 100 90 131 74 93
Prabu B 33 M 51-22295067 76 175 24.81633 I I I 108 134 70 91.3333333 100 10 12 107 132 70 90.6666667 100 105 130 70 90
Bupesh B 29 M 51-22647388 64 157 25.96454 I II I 88 108 76 86.6666667 100 10 18 92 112 78 89.3333333 100 94 106 74 84.667
Kannian D 40 M 51-15225102 68 168 24.09297 II I I 88 136 76 96 99 5 4 80 130 70 90 100 82 130 80 96.7
 Annadurai B 45 M 51-13435637 76 174 25.10239 II I I 104 150 94 112.666667 100 10 14 102 142 98 112.666667 100 100 148 90 109.33
Natarajan B 53 M 51-22374248 69 176 22.27531 II I I 102 100 70 80 100 10 16 100 102 70 80.6666667 100 92 104 68 80
Manoj kumar D 19 M 51-22112248 58 162 22.10029 I II I 86 128 68 88 100 5 4 84 126 74 91.3 100 80 124 72 89.3
 Anthoniammal D 26 F 51-1661216 58 162 22.10029 I II I 90 109 68 81.7 100 10 4 92 112 72 85.3 100 82 104 74 84
Jeyaraman B 49 M 51-22586063 75 179 23.40751 I II I 92 110 72 84.6666667 100 15 10 96 112 72 85.3333333 100 94 114 72 86
Selvam D 42 M 51-16684712 60 172 20.28123 I III I 98 126 86 99 99 10 4 86 120 82 94.7 100 78 120 78 92
 Neela B 60 F 51-13255005 62 165 22.77319 II I I 82 108 74 85.3333333 100 15 18 88 109 74 85.6666667 100 82 104 72 82.667
Kokila B 37 F 51-22072836 66 169 23.10843 I I I 84 124 72 89.3333333 100 5 14 82 128 90 102.666667 100 86 126 70 88.667
Jaya D 32 F 51-2184650 58 158 23.23346 I III II 104 142 76 98 100 10 2 90 138 72 94 100 92 136 72 93.3
Raji B 25 M 51-15362810 66 172 22.30936 I III II 76 132 70 90.6666667 100 10 16 78 130 72 91.3333333 100 78 128 78 94.667
Jayalakshmi B 58 F 51-13150201 64 164 23.79536 II II I 98 120 70 86.6666667 100 10 12 94 122 74 90 100 102 124 72 89.333
Arumugam D 29 M 51-17157715 64 164 23.79536 I I I 92 132 72 92 100 10 4 90 132 70 90.7 100 92 131 72 91.7
Sathish kumar B 42 M 51-14408541 70 168 24.80159 II II I 78 124 74 90.6666667 100 15 10 88 132 76 94.6666667 100 102 134 70 91.333
Durai raj D 53 M 51-17396017 70 174 23.12062 II II I 102 146 76 99.3 99 10 4 100 140 72 94.7 99 88 140 70 93.3
Abdul kadher B 29 M 51-17295652 71 169 24.85907 I II I 84 122 70 87.3333333 100 15 20 92 140 90 106.666667 100 88 132 70 90.667
Sadagopan B 49 M 51-22810291 65 162 24.76757 I II I 90 112 78 89.3333333 100 5 12 102 120 72 88 100 90 114 72 86
Vasanthi D 48 F 51-16708888 58 162 22.10029 II I I 98 132 76 94.7 99 5 6 78 130 72 91.3 99 72 126 78 94
Balasubramanian B 18 M 51-15373629 72 165 26.44628 I II I 92 104 74 84 100 10 18 88 114 74 87.3333333 100 86 124 70 88
Priya ranjan das D 28 F 51-21105433 52 158 20.83 I II I 88 112 68 82.7 100 10 6 80 110 70 83.3 100 82 108 74 85.3
Shankar B 45 M 51-16682279 62 159 24.52435 II III II 68 104 78 86.6666667 100 15 12 76 108 72 84 100 82 110 70 83.333
Paraimala B 44 F 51-20504311 79 176 25.50362 II I I 96 104 62 76 100 10 8 102 108 74 85.3333333 100 98 106 72 83.333
Umesh raj B 28 M 51-22503174 68 167 24.38237 I II I 72 124 74 90.6666667 100 10 8 82 120 70 86.6666667 100 88 126 74 91.333
manoj kumar D 51 M 51-17773028 79 165 29.01745 II II I 84 140 98 112 99 10 2 82 132 78 96 100 82 130 72 91.3
manoharan D 54 M 51-66323018 72 171 24.62296 II II I 98 102 62 75.3 100 10 4 92 110 70 83.3 100 84 122 74 90
Albert robinson D 25 M 51-17614602 66 162 25.14861 I II II 89 100 70 80 100 10 4 74 102 76 84.7 100 76 104 74 84
Johnwestley B 21 M 51-17551091 72 172 24.33748 I II I 78 98 70 79.3333333 100 15 10 88 100 72 81.3333333 100 82 100 72 81.333
Mahendran D 32 M 51-15622744 69 168 24.44728 I I I 106 136 86 102.7 99 10 4 82 132 78 96 100 78 132 72 92
Karthikeyan D 24 M 51-21963256 67 168 23.73866 I II I 88 120 74 89.3 100 5 6 98 118 74 88.7 100 92 118 64 82
Arumugam B 31 M 51-21367524 74 176 23.88946 I I I 104 132 70 90.6666667 100 5 12 92 134 70 91.3333333 100 90 130 72 91.333
 Vigneswaran D 23 M 51-20880248 70 169 24.50895 I II I 108 120 70 86.7 100 5 4 88 118 72 87.3 100 82 116 78 90.7
Thanikesan D 58 M 51-17430796 76 178 23.98687 II II I 86 120 82 94.7 100 10 4 86 130 80 96.7 100 84 122 78 91.3
Naresh Rai B 34 M 51-20422716 69 174 22.79033 I I I 108 130 90 103.333333 100 15 12 102 128 76 93.3333333 100 92 120 70 86.667
Babu D 27 M 51-2245288 69 172 23.32342 I III II 92 132 70 90.7 100 5 6 92 118 74 88.7 100 84 124 72 89.3
Senthil D 31 M 51-17247114 70 171 23.93899 I I I 96 130 84 99.3 99 10 4 88 128 80 96 100 86 122 80 94
Kalaiarasan B 23 M 51-20030920 69 170 23.87543 I II I 98 140 90 106.666667 100 15 14 104 132 70 90.6666667 100 98 130 72 91.333
Sathish B 33 M 51-11166707 80 177 25.53545 I II I 106 122 72 88.6666667 100 15 16 98 132 70 90.6666667 100 99 132 82 98.667
Prabakaran D 21 M 51-162 46180 62 168 21.96712 I II I 112 110 72 83.3 100 15 4 109 132 70 90.7 98 102 114 70 84.7
Murugan D 38 M 51-13349928 64 163 24.08822 I I I 98 104 72 82.7 100 5 4 102 108 72 84 100 98 126 70 88.7
Paneerselvam B 48 M 51-21708635 72 168 25.5102 I I I 84 132 70 90.6666667 100 15 18 92 138 80 99.3333333 100 92 126 78 94
Isravel D 42 M 51-16258990 68 164 25.28257 I III I 106 122 70 87.3 100 5 4 102 120 82 94.7 100 98 118 70 86
Khokanmajundar B 21 M 51-12352922 65 169 22.75831 I II I 82 144 74 97.3333333 100 10 20 90 130 90 103.333333 100 102 136 70 92
Mohan B 21 M 51-23118538 63 157 25.55885 I III I 86 118 72 87.3333333 100 10 12 90 128 70 89.3333333 100 88 132 70 90.667
Muthu velayudum D 29 M 51-22080634 67 178 21.14632 I I I 78 120 74 89.3 100 5 6 84 118 72 87.3 100 82 120 60 80
Palani B 40 M 51-20468677 70 168 24.80159 II II I 102 112 72 85.3333333 100 10 10 104 122 90 100.666667 100 98 128 70 89.333
Gnanasekaran B 25 M 51-23188203 69 174 22.79033 I II I 98 108 68 81.3333333 100 10 20 102 106 74 84.6666667 100 98 110 74 86
Dharmarajan D 32 M 51-20797346 69 165 25.34435 I II I 108 118 76 90 100 5 4 108 118 72 87.3 100 106 116 74 88
Natarajan D 28 M 51-15812875 64 164 23.79536 I I I 92 114 73 86.7 100 5 2 88 102 72 82 100 82 108 72 84
Narayanan B 51 M 51-17342822 71 168 25.1559 II II I 88 128 70 89.3333333 100 10 12 92 128 70 89.3333333 100 98 124 76 92
Velmurugan D 27 M 51-15922802 66 164 24.53896 I III I 102 120 72 88 100 5 4 92 122 68 86 100 90 124 62 82.7
Babu D 32 M 51-1582857 64 159 25.31545 I III I 102 100 72 81.3333333 100 5 4 90 112 70 84 100 82 109 74 85.667
Senthamizh B 37 F 51-14449595 62 155 25.80645 I II I 82 112 68 82.6666667 100 15 8 98 118 70 86 100 102 116 72 86.667
Arumugam D 53 M 51-17636642 69 166 25.03992 II I I 94 114 64 80.7 100 10 4 94 128 64 85.3 100 92 124 72 89.3
Ramadoss B 24 M 51-15819139 65 158 26.03749 I II I 98 122 70 87.3333333 100 5 14 98 126 72 90 100 102 124 72 89.333
Ramesh D 23 M 51-21410823 72 170 24.91349 I III II 96 112 68 82.7 100 15 6 96 108 72 84 100 94 108 71 83.3
Nirmala B 40 F 51-14416972 70 166 25.40282 II II II 98 104 74 84 100 5 12 98 116 72 86.6666667 100 98 122 70 87.333
Udayakumar D 24 M 51-21652667 76 174 25.10239 I III II 88 108 78 88 100 5 4 86 108 70 82.7 100 84 106 72 83.3
Govindhasamy B 50 M 51-21224619 76 178 23.98687 II I I 104 112 72 85.3333333 100 10 14 98 122 76 91.3333333 100 92 112 74 86.667
praburaj D 29 M 51-16840208 59 164 21.93635 I III II 84 107 76 86.3 100 10 4 86 107 74 85 100 84 108 70 82.7
Jeyaraj D 28 M 51-22506162 62 164 23.05175 I I I 76 110 72 84.7 100 5 6 86 112 70 84 100 88 122 76 91.3
Babu D 34 M 51-1381O418 72 173 24.05693 I II I 86 106 70 82 100 5 4 84 106 70 82 100 82 128 74 92
Ramesh D 48 M 51-13512946 60 159 23.73324 II III II 104 112 70 84 100 15 4 102 108 72 84 100 106 112 72 85.3
Anbukannan B 35 M 51-22098288 65 156 26.7094 II II I 72 108 72 84 100 10 20 88 120 70 86.6666667 100 82 134 72 92.667
Mani B 48 M 51-22924421 64 159 25.31545 I III I 108 114 62 79.3333333 99 10 12 102 118 76 90 100 98 120 76 90.667
Sabarish D 18 M 51-16652909 59 158 23.63403 I II I 98 118 76 90 100 5 4 98 124 74 90.7 100 98 122 72 88.7
Venkatesh B 51 M 51-15717675 64 156 26.29849 I II I 98 108 70 82.6666667 100 10 10 102 110 72 84.6666667 100 98 114 74 87.333
vijayalakshmi D 32 M 51-13850364 61 162 23.24341 I II I 92 109 62 77.7 100 5 4 108 108 64 78.7 99 107 108 62 77.3
kalaimani B 31 M 51-23347731 65 162 24.76757 I II I 92 104 68 80 100 15 12 102 112 70 84 100 100 118 ######
 Harikrishnan D 38 M 51-13069013 62 161 23.91883 I II I 89 100 76 84 100 5 4 102 103 70 81 100 91 105 74 84.3
Thangasamy B 28 M 51-23543781 68 154 28.67263 I II I 88 110 70 83.3333333 100 15 14 92 116 72 86.6666667 100 98 124 78 93.333
Sasikala B 53 F 51-17652629 50 148 22.82688 II III I 78 124 80 94.6666667 100 15 10 96 130 72 91.3333333 100 92 130 70 90
Mohanrajan B 47 M 51-11933469 66 154 27.82931 II II I 94 106 78 87.3333333 100 15 15 102 112 78 89.3333333 100 98 120 76 90.667
SPO2-15 PR-30 SYS-30 DIA-30 MAP-30 SPO2-30PR_45SYS_45DIA_45 MAP_45 SPO2_45PR_60SYS-60DIA_60 MAP_60SUR_DURDUR_ANP_1 P_2 P_3 P-4 P-5 P_6 P_7 P_8 P_9 P_10 P_12 P-14 P-16 P-18 P_20 P_22 P-24
99 76 127 78 94 99 74 126 76 92.6666667 99 74 122 72 88.6666667 3 18 VO VO VO VO VO VO VO VO VO V2 V4
100 102 120 79 92.6667 100 98 124 74 90.6666667 100 98 122 72 88.6666667 5 12 VO VO V2 V2 V4
100 90 128 74 92 100 84 122 74 90 100 82 128 72 90.6666667 3 16 VO VO VO VO VO VO VO VO V2 V4
100 84 122 70 87 100 80 124 72 89.3333333 100 76 118 70 86 3.3 18 VO VO VO VO VO VO VO VO VO V2 V4
100 104 140 72 94.6667 100 98 132 90 104 100 98 130 70 90 4.3 8 VO V2 V2 V4
100 86 129 72 91 100 86 128 72 90.6666667 100 72 124 70 88 5 16 VO VO VO VO VO VO V2 V4
100 102 128 74 92 100 100 126 76 92.6666667 100 102 130 72 91.3333333 4 9 VO VO V2 V4
100 98 120 72 88 100 82 108 72 84 100 92 106 74 84.6666667 4 10 VO VO VO VO V2 V4
100 84 128 72 91 100 88 122 80 94 100 88 122 80 94 1 14 VO VO VO VO VO VO VO VO VO V2 V4
100 98 148 70 96 100 102 146 84 104.666667 100 94 142 72 95.3333333 4 10 VO VO V4
100 104 108 72 84 100 96 108 62 77.3333333 100 102 106 70 82 3 7 VO V2 V4
100 78 122 72 89 100 78 120 72 88 100 78 120 70 86.6666667 2 22 VO VO VO VO VO VO VO VO VO VO VO VO V2 V4
100 84 102 78 86 100 92 108 78 88 100 94 109 72 84.3333333 3 20 VO VO VO VO VO VO VO VO VO VO VO V4
100 92 116 74 88 100 94 112 72 85.3333333 100 94 110 72 84.6666667 4 6 VO V4
100 76 122 71 92 100 74 122 70 87 100 76 122 70 87.3333333 4 18 VO VO VO VO VO VO V2 V2 V2 V4
100 86 106 72 83.3333 100 84 104 70 81.3333333 100 92 102 68 79.3333333 3 8 VO VO VO VO V4
100 84 124 70 88 100 82 122 72 88.6666667 100 84 120 70 86.6666667 2.4 9 VO VO V2 V2 V4
100 86 142 74 97 100 78 142 74 96.6666667 100 76 138 70 92.6666667 3 12 VO VO VO VO VO VO VO V4
100 82 126 72 90 100 84 120 70 86.6666667 100 82 114 76 88.6666667 3 12 VO VO VO VO V2 V4
100 94 124 68 86.6667 100 96 120 72 88 100 94 118 76 90 3.3 8 VO V2 V4
100 78 126 70 89 100 74 128 70 89.3333333 100 74 124 68 86.6666667 1.2 16 VO VO VO VO VO VO VO VO VO VO V2 V4
100 82 128 78 94.6667 100 102 118 70 86 100 78 116 74 88 4 10 VO VO VO VO V2 V4
99 76 138 71 93 99 76 145 72 96.3333333 99 76 136 70 92 2 16 V0 VO VO VO VO VO VO VO VO VO V2 V4
100 92 120 90 100 100 82 116 70 85.3333333 100 84 107 90 95.6666667 3 6 VO VO V2 V4
100 104 104 74 84 100 84 112 70 84 100 94 114 72 86 3 9 VO VO VO VO V2 V4
100 74 122 74 90 100 80 122 74 90 100 80 118 74 88.6666667 2 18 VO VO VO VO VO VO VO VO VO V2 V2 V4
100 102 110 78 88.6667 100 92 118 74 88.6666667 100 86 110 84 92.6666667 3.3 9 VO VO VO V2 V4
100 80 106 72 83 100 84 144 78 100 100 84 139 74 95.6666667 3 18 VO VO VO VO VO VO VO VO VO VO V4
100 90 114 78 90 100 86 120 70 86.6666667 100 74 110 70 83.3333333 1 12 VO VO VO VO VO VO VO VO V2 V4
100 90 108 72 84 100 98 98 72 80.6666667 100 82 104 82 89.3333333 3 10 VO VO VO VO VO V2 V4
100 86 120 70 86.6667 100 90 118 72 87.3333333 100 78 112 74 86.6666667 4 6 VO VO V4
100 82 126 70 89 100 82 126 72 90 100 82 122 74 90 4 18 VO VO VO VO VO VO VO V2 V2 V4
100 78 120 72 88 100 86 122 74 90 100 82 120 72 88 3 22 VO VO VO VO VO VO VO VO VO VO V2 V4
100 76 105 72 83 100 76 114 72 86 100 70 108 70 82.6666667 4 24 VO VO VO VO VO VO VO VO VO VO V0 V2 V4
100 84 114 72 86 100 80 112 70 84 100 80 108 72 84 1.3 8 VO VO VO VO VO V4
100 74 131 70 90 100 76 130 80 96.6666667 100 74 124 76 92 3 20 VO VO VO VO VO VO VO VO VO VO V2 V4
100 86 120 72 88 100 84 120 70 86.6666667 100 76 112 72 85.3333333 2.3 20 VO VO VO VO VO VO VO VO VO VO V2 V4 V0
100 78 128 70 89.3333 100 84 134 78 96.6666667 100 98 124 74 90.6666667 2 10 VO VO VO VO VO VO V2 V4
100 76 114 72 87 100 74 126 68 87.3333333 100 72 112 64 80 3 18 VO VO VO VO VO VO VO VO VO V2 V4
100 84 122 76 91 100 84 120 76 90.6666667 100 84 120 72 88 2 16 VO VO VO VO VO VO VO VO VO V0 V4
100 82 112 72 85.3333 100 94 120 72 88 100 102 114 70 84.6666667 4.4 8 VO VO VO VO V2 V4
100 86 112 74 87 100 94 114 72 86 100 92 112 70 84 2 18 VO VO VO VO VO VO VO VO V2 V4
100 84 120 80 93 100 82 124 82 96 100 82 120 80 93.3333333 4 20 VO VO VO VO VO VO VO VO VO V2 V4
100 98 128 72 90.6667 100 98 124 70 88 100 92 132 72 92 3 8 VO
100 98 136 70 92 100 88 130 72 91.3333333 100 88 120 70 86.6666667 3 10 VO VO VO VO VO V2 V4
100 98 112 70 84 100 96 132 70 90.6666667 100 82 134 78 96.6666667 3 22 VO VO VO VO VO VO VO VO VO VO VO V4
100 96 118 70 86 100 92 116 70 85.3333333 100 90 108 74 85.3333333 4 20 VO VO VO VO VO VO VO VO VO V2 V4
100 94 114 70 84.6667 100 98 120 70 86.6666667 100 102 126 74 91.3333333 3 9 VO VO VO VO V2 V4
100 96 116 70 85 100 94 114 72 86 100 84 110 70 83.3333333 1 20 VO VO VO VO VO VO VO VO VO VO VO VO VO VO V4
100 98 128 74 92 100 98 122 72 88.6666667 100 98 118 72 87.3333333 4.3 8 VO VO V2 V4
100 92 126 72 90 100 92 122 72 88.6666667 100 86 128 70 89.3333333 1.1 7 VO VO VO VO VO V4
100 78 118 72 87 100 76 120 72 88 100 78 116 70 85.3333333 4 14 VO VO VO VO VO VO V2 V4
100 102 124 76 92 100 102 118 72 87.3333333 100 98 102 78 86 3.4 9 VO VO VO VO V2 V4
100 98 112 72 85.3333 100 92 106 70 82 100 90 108 76 86.6666667 3 9 VO VO VO VO V0 V4
100 105 118 74 89 100 106 118 74 88.6666667 100 98 116 74 88 2.2 18 VO VO VO VO VO VO VO VO VO VO VO V2 V4
99 75 102 74 83 99 78 108 74 85.3333333 100 72 104 72 82.6666667 4.3 20 VO VO VO VO VO VO VO V2 V2 V4
100 102 122 76 91.3333 100 94 118 72 87.3333333 100 92 110 72 84.6666667 3.3 12 VO VO VO VO VO VO VO V4
100 92 116 78 91 100 94 118 76 90 100 88 114 74 87.3333333 1 22 VO VO VO VO VO VO VO VO VO VO VO VO V2 V4
100 78 108 78 88 99 82 102 72 82 100 82 100 74 82.6666667 3 18 VO VO VO VO VO VO V2 V2 V4
100 98 122 70 87.3333 100 96 120 70 86.6666667 100 96 114 64 80.6666667 4 8 VO VO V2 V4
100 90 121 76 91 100 91 122 74 90 100 89 120 74 89.3333333 4 20 VO VO VO VO VO VO VO VO VO VO V4
100 98 118 72 87.3333 100 98 120 68 85.3333333 100 102 118 72 87.3333333 4 10 VO VO VO VO V2 V4
100 94 106 62 77 100 92 107 64 78.3333333 100 96 102 74 83.3333333 1.3 20 VO VO VO VO VO VO VO VO VO VO VO VO VO V2 V4
100 102 130 72 91.3333 100 96 128 82 97.3333333 100 98 120 64 82.6666667 3 10 VO VO VO VO VO V2 V4
100 86 102 72 82 100 84 104 68 80 100 82 102 60 74 2 22 VO VO VO VO VO VO VO VO VO VO VO VO V4
100 98 102 70 80.6667 100 94 100 62 74.6666667 100 90 104 72 82.6666667 4 8 VO VO V2 V4
100 88 110 70 83 100 86 130 72 91.3333333 100 82 127 72 90.3333333 1.3 22 VO VO VO VO VO VO VO VO VO VO VO VO V2 V4
100 86 126 74 91 100 84 124 74 90.6666667 100 82 116 72 86.6666667 2 18 VO VO VO VO VO VO VO VO VO V2 V4
100 84 128 74 92 100 86 131 72 91.6666667 100 84 129 72 91 2.3 18 VO VO VO VO VO VO VO VO VO VO V2 V4
100 98 110 72 85 100 96 132 72 92 100 98 128 74 92 1.3 22 VO VO VO VO VO VO VO VO VO V2 V4
100 84 130 72 91.3333 100 82 132 72 92 100 84 124 72 89.3333333 3 12 VO VO VO VO VO VO V2 V4
100 98 122 70 87.3333 100 102 118 72 87.3333333 100 98 114 72 86 4 12 VO VO VO VO V2 V2 V4
100 96 122 72 89 100 94 121 76 91 100 97 120 68 85.3333333 1 18 VO VO VO VO VO VO VO VO VO VO V2 V4
100 98 120 68 85.3333 100 98 118 70 86 100 96 108 72 84 2 9 VO VO VO VO VO V2 V4
100 102 102 62 75 100 98 104 68 80 100 98 106 62 76.6666667 3 20 VO VO VO VO VO VO VO VO V2 V2 V4
100 98 118 72 87.3333 100 104 114 72 86 100 94 120 70 86.6666667 3 6 VO V2 V4
100 88 102 72 82 100 92 105 72 83 100 82 102 70 80.6666667 5 24 VO VO VO VO VO VO VO VO VO VO V2 V4
100 96 120 76 90.6667 100 98 116 75 88.6666667 100 92 122 74 90 5 10 VO VO VO VO V4
100 90 128 70 89.3333 100 90 130 74 92.6666667 100 84 122 70 87.3333333 1 8 VO VO VO VO V2 V4
100 102 124 74 90.6667 100 98 122 76 91.3333333 100 92 120 72 88 3 12 VO V0 VO VO VO VO V2 V4
S

KEY TO MASTER CHART
GROUPS
D (STUDY )  ---- DEXAMETHASONE  GROUP
B  ( CONTROL)------- BUPIVACAINE GROUP
LEVEL OF SURGERY
     I  -    ELBOW AND ABOVE ELBOW SURGERIES.
     II  -   FOREARM SURGERIES
    III  - HAND SURGERIES.
 TYPE OF SURGERY
      I   -  ELECTIVE
     II  - EMERGENCY
ON_SB      –       ONSET OF SENSORY BLOCK.
ON_MB  –     ONSET OF MOTOR  BLOCK.
DUR _SUR  -   DURATION OF SURGERY.
DUR_ AN  -  DURATION OF ANALGESIA.
P_1  TO P_24   -     Ist     HOUR OF  POSTOPERATIVE PERIOD  TO    24 th  OF
POSTOPERATIVE PERIOD.
VO  - VAS SCORE OF O
V2  -  VAS SCORE  OF 2
V4  -  VAS SCORE OF   4


